abl kinase domain bound to inhibitor
Published 12 years ago • 516 plays • Length 0:34Download video MP4
Download video MP3
Similar videos
-
4:04
breaking bcr-abl resistance
-
20:53
bcr-abl tyrosine kinase inhibitors - nc, se, ts
-
0:50
molecular dynamics of the erlotinib-bound tyrosine kinase domain of egfr
-
4:02
testing for bcr::abl kinase mutations in cml and how they impact tki resistance
-
0:07
abl kinase domain
-
1:08
ngs for kd mutational analysis in cml patients on tkis
-
1:09
kinase domain mutation screening in patients with ph all and cml
-
3:00
bcr-abl1 and the philadelphia chromosome - part 3: the bcr-abl fusion protein
-
6:29
chronic myeloid leukemia: understanding loss of response
-
4:31
managing toxicities from bcr-abl tkis in cml
-
11:57
receptor tyrosine kinases (rtks) - part 1: domains
-
0:44
reynaldo garcia on cml bcr-abl testing recommendation
-
2:11
addressing the issue of resistance to tkis in cml
-
2:07
egf receptor cytoplasmic tyrosine kinase domain (with sound)
-
3:41
resistance to btk inhibitors in b-cell malignancies
-
1:22
dual abl1 inhibition in elderly all: asciminib, dasatinib, prednisone
-
1:37
inhibition of abl tyrosine kinases shows potential for metastatic cancer treatment
-
13:38
receptors with tyrosine kinase domains !
-
2:54
protein kinases: cell signaling and phosphorylation